Marla C Dubinsky, MD
img_Marla C Dubinsky
PROFESSOR | Pediatrics, Gastroenterology
PROFESSOR | Medicine, Gastroenterology
Are you a patient?
Pediatrics, Pediatric Gastroenterology
Research Topics
Inflammatory Bowel Disease (IBD), Personalized Medicine, Pharmacogenomics
Dr. Dubinsky's research interests include:
  • Microbiome and genetics
  • Pharmacogenetics
  • Pregnancy, preconception, and fertility
  • Prognostic models
  • Therapeutic drug monitoring

MD, Royal College of Physicians

Residency, Pediatrics, Alberta Childrens Hospital

Fellowship, Pediatric Gastroenterology, CHU Sainte Justine


American Board of Pediatrics


Sherman Prize Recipient


International Organization for the Study of Inflammatory Bowel Disease


Abe and Claire Levine Chair in Pediatric Inflammatory Bowel Disease


Lectureship Award, University of Calgary


Corrine and Lenny Sands Clinical Investigator Award

The importance of Collaboration of Care Across Pediatric Gastroenterology, Pediatric Liver and IBD
Crohn’s Disease in Children
A Personalized Approach to IBD: From Prediction to Prevention
Marla C. Dubinsky, MD, discusses the unique and personalized gastroenterology care offered

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Dubinsky during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Board Service

  • Trellus Health

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Bristol-Myers Squibb
  • Merck & Co., Inc.
  • Abivax
  • Eli Lilly And Company
  • Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
  • prometheus biosciences
  • Takeda Pharmaceuticals Of North America, Inc.
  • AbbVie, Inc.
  • target rwe
  • cornerstones health
  • Gilead Sciences
  • Pfizer Inc., U.S. Pharmaceuticals Group

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Trellus Health


  • cornerstones health
  • Trellus Health

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.